| Sign In to gain access to subscriptions and/or personal tools. |
Human metabolism of aluminium-26 and gallium-67 injected as citratesBiomedical Research Department, AEA Technology, 551 Harwell, Didcot, Oxon, OX11 ORA, UK
Biomedical Research Department, AEA Technology, 551 Harwell, Didcot, Oxon, OX11 ORA, UK
Department of Chemistry, University of Manchester, Manchester M13 9PL, UK
Biomedical Research Department, AEA Technology, 551 Harwell, Didcot, Oxon, OX11 ORA, UK
Biomedical Research Department, AEA Technology, 551 Harwell, Didcot, Oxon, OX11 ORA, UK 1 26Al and 67Ga were given as citrates to a healthy male volunteer by intravenous injection. The retention of both tracers was studied by body radioactivity measurement. Levels in blood and excreta were determined by y-ray spectrometry and/or accelerator mass spectrometry.
2 More than half of the 26Al had left the blood after 15 min and the decline continued, leaving <1% in blood after 2 d; the losses occurred both to renal excretion and through uptake by other compartments. Estimated excre tion up to 13 d was 83% (urine) and 1.8% (faeces). Whole-body retention of 15% at 13 d declined to 3 The metabolism of 67Ga differed markedly from that of 26Al in all aspects studied.
Key Words: aluminium gallium injection retention excretion
Human & Experimental Toxicology, Vol. 14, No. 3,
287-293 (1995) This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
4% at 1178 d, when the daily reduction corresponded to a bio logical half-life of 7 y, suggesting that sustained intake of dietary aluminium may lead to a progressively increas ing internal deposit. 

